Novartis India fixes Book Closures for Dividend & AGM
Novartis India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 09, 2008 to July 16, 2008 (both days inclusive) for the purpose of payment of dividend & 60th Annual General Meeting (AGM) of the Company. Novartis India Board recommends dividend
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2008, inter alia, has recommended a dividend of 200% (Rs 10/- per equity share of Rs 5 each) for the year ended March 31, 2008. Novartis India Board to consider dividend
Novartis India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 09, 2008, inter alia, to consider the following:1. Adoption of Annual accounts for the year ended March 31, 2008.2. Recommend dividend for the period mentioned above. Novartis India to publish Audited FY 08 results
Novartis India Ltd has informed BSE that the Company will publish audited accounts for the financial year ended March 31, 2008. Accordingly, the Company shall not publish the Unaudited Financial Results (Provisional) of the Company for the quarter ended March 31, 2008. Novartis India announces Q3 results
Novartis India Ltd has announced the following Unaudited results for the quarter ended December 31, 2007:The Company has posted a net profit of Rs 224.70 million for the quarter ended December 31, 2007 as compared to Rs 210.70 million for the quarter ended December 31, 2006. Total Income has decreased from Rs 1585.10 million for the quarter ended December 31, 2006 to Rs 1525.90 million for the quarter ended December 31, 2007. Novartis India - Q3 results on Jan 25, 2008
Novartis India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 25, 2008, inter alia, to consider the third quarter results of the Company for the period ended December 31, 2007 (Q3). Novartis India - Updates
Novartis India Ltd has informed BSE that Dr. E Schillinger has resigned from the Board of Directors of the Company and ceases to be the Chairman of the Board of Directors. Dr. P Jager has been appointed as Director and succeeds Dr. Schillinger as the Chairman of the Board of Directors. Both these changes are with effect from October 23, 2007. Novartis India announces Q2 results
Novartis India Ltd has announced the following Unaudited results for the quarter ended September 30, 2007:The Company has posted a net profit of Rs 303.90 million for the quarter ended September 30, 2007 as compared to Rs 178.70 million for the quarter ended September 30, 2006. Total Income has increased from Rs 1382.50 million for the quarter ended September 30, 2006 to Rs 1639.70 million for the quarter ended September 30, 2007. Novartis India - Q2 results on Oct 23, 2007
Novartis India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 23, 2007, inter-alia, to consider the unaudited Financial Results of the Company for the period ended September 30, 2007 (Q2). Novartis India - Updates on Outcome of AGM
Novartis India Ltd has informed BSE that the members at the 59th Annual General Meeting (AGM) of the Company held on July 20, 2007, inter alia, have accorded to the following:1. Declaration of interim dividend of 200% (i.e. Rs 10/- per share), as Final Dividend.2. Appointment of Messrs. Price Waterhouse, Chartered Accountants, as Auditors of the Company for the financial year ending on March 31, 3008, on remuneration, terms & conditions....